Treatment Approach for MSI-H/dMMR CRC

 

Cleveland Clinic Taussig Cancer Institute
F

Prognostic and Predictive Value of Microsatellite Instability Status Among Patients With Colorectal Cancer

By Cleveland Clinic Taussig Cancer Institute FEATURING Firas Baidoun
By Cleveland Clinic Taussig Cancer Institute FEATURING Firas Baidoun
192 views
March 16, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Approach for MSI-H/dMMR CRC
05:20
ecancer

ASCO 2021 Update on Pembrolizumab vs. Chemo in MSI-H/dMMR mCRC: Fina…

Feat. T. André
30:44
LARVOL

ASCO 2021 Highlights on Advanced Gastrointestinal Cancers: 1L Nivo +…

Feat. M. Salem, M. Lewis, K. Knopf
27:09
2021 Virtual ESMO Review

ESMO 2021 Upper GI Updates: Advanced ESCC and GEJ, HER2+ GC, CAR T, …

Feat. S. Klempner
20:33
UChicago Medicine: Sixth Annual Updates in Digestive Diseases

Colon Cancer Screening and Surveillance in 2021

Feat. N. Sengupta
16:08
UChicago Medicine: Sixth Annual Updates in Digestive Diseases

Updates in Genetic Testing for Familial Cancers

Feat. C. Drogan
07:51
University of Colorado Cancer Center

Updates in dMMR/MSI CRC: Overview of Recent Immunotherapy Advances

Feat. W. Messersmith
18:08
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Updates in Management of mCRC in Era of Comprehensive Genomic Analys…

Feat. C. Wu
44:02
Total Health

Expert Discussion on mCRC: Pembro vs. Chemo for MSI-H dMMR Disease, …

Feat. S. Jain, M. Cho, C. Eng, A. Loaiza-Bonilla, A. Parikh
09:44
ASCO GI 2022 Conference Coverage

ASCO GI 2022 Highlights: Clinical Utility of MSI-H Identified on Liq…

Feat. P. Kasi
14:06
ASCO GI 2022 Conference Coverage

ASCO GI 2022 on the Emerging Roles of ctDNA as a Tool in Metastatic …

Feat. A. Dasari
34:34
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Immunology & IO in Lynch Syndrome: Immune System, MSI & Here…

Feat. M. J. Hall
20:38
Nilofer Saba Azad

Emerging Approaches for Immunotherapy in CRC

20:26
Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

Incidental Findings From Somatic Testing and Implications for Heredi…

Feat. Z. Stadler
10:48
Daniel Ahn

Chemo & IO in MSI-H mCRC: What the Oncologist Should Know

24:51
UNC Lineberger Comprehensive Cancer Center

Updates in Treatment Sequencing by Molecular Profile in CRC and Bili…

Feat. H. K. Sanoff
13:15
Penn Medicine Abramson Cancer Center

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Feat. M. Soulen
15:26
Chiara Cremolini

Utilizing Single-Agent Immunotherapy in MSI-H CRC

19:03
2022 West Oncology Conference

Therapeutic Advances in CRC: The Real Deal or Just Hype?

Feat. V. Morris
11:02
Cleveland Clinic Taussig Cancer Institute

Prognostic and Predictive Value of Microsatellite Instability Status…

Feat. F. Baidoun
04:11
ASCO 2022 Conference Coverage

ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (COMMIT) Phase 3 Stu…

Feat. M. Overman
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (C…

Feat. M. Overman
08:41
ASCO 2022 Conference Coverage

ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…

Feat. R. Kim
01:02
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Pembrolizumab + mFOLFOX7/FOLFIRI for …

Feat. R. Kim